cycloserine has been researched along with apomorphine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Huber, VJ; Nakada, T; Tsujita, M | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Dall'Olio, R; Gandolfi, O | 1 |
Dall'Olio, R; Gandolfi, O; Rimondini, R | 1 |
Dall'Olio, R; Gandolfi, O; Locchi, F; Rimondini, R; Voltattorni, M | 1 |
1 review(s) available for cycloserine and apomorphine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for cycloserine and apomorphine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Identification of aquaporin 4 inhibitors using in vitro and in silico methods.
Topics: Aquaporin 4; Computer Simulation; Humans; Inhibitory Concentration 50; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2009 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzazepines; Cycloserine; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Stereotyped Behavior | 1993 |
The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Cycloserine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Grooming; Male; Methamphetamine; Motor Activity; N-Methylaspartate; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride | 1994 |
An ionotropic but not a metabotropic glutamate agonist potentiates the pharmacological effects of olanzapine in the rat.
Topics: Amphetamines; Animals; Apomorphine; Benzodiazepines; Cycloserine; Dopamine Agonists; Drug Synergism; Excitatory Amino Acid Agonists; Exploratory Behavior; Glycine; Injections, Intraventricular; Male; Motor Activity; Olanzapine; Phenylacetates; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior | 2005 |